Read More Pharma Industry News Pfizer Q3 2025 earnings beat forecasts as non-COVID drug sales lift margins and EPS guidance Find out how Pfizer beat Q3 2025 earnings forecasts and raised full-year EPS guidance as non-COVID drugs and cost savings drove profit growth. bySoujanya RaviNovember 4, 2025